INVESTMENTS AND FAIR VALUE MEASUREMENTS (Tables)
|
12 Months Ended |
Apr. 30, 2026 |
|---|
| INVESTMENTS AND FAIR VALUE MEASUREMENTS |
|
| Schedule of current investments |
|
|
|
|
|
|
|
|
|
|
|
April 30,
2026 |
|
|
April 30,
2025 |
|
Investments – current |
|
|
|
|
|
|
Marketable-equity securities |
|
$ |
42,168 |
|
|
$ |
55,784 |
|
U.S. treasury securities |
|
|
— |
|
|
|
33,005 |
|
Total Investments – current |
|
$ |
42,168 |
|
|
$ |
88,789 |
|
|
| Schedule of noncurrent investments |
|
|
|
|
|
|
|
|
|
|
|
April 30,
2026 |
|
|
April 30,
2025 |
|
Investments – noncurrent |
|
|
|
|
|
|
Corporate bonds |
|
|
— |
|
|
|
13,880 |
|
Total Investments – noncurrent |
|
$ |
— |
|
|
$ |
13,880 |
|
|
| Schedule of short-term investments |
Marketable securities consisted of the following as of these periods (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
April 30, 2026 |
|
|
|
Cost or
Amortized Cost |
|
|
Unrealized
Gains |
|
|
Unrealized
Losses |
|
|
Fair Value |
|
Marketable-equity securities |
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities |
|
$ |
47,087 |
|
|
$ |
5,365 |
|
|
$ |
(10,284 |
) |
|
$ |
42,168 |
|
Total marketable securities |
|
$ |
47,087 |
|
|
$ |
5,365 |
|
|
$ |
(10,284 |
) |
|
$ |
42,168 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
April 30, 2025 |
|
|
|
Cost or
Amortized Cost |
|
|
Unrealized
Gains |
|
|
Unrealized
Losses |
|
|
Fair Value |
|
Marketable-equity securities |
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities |
|
$ |
63,677 |
|
|
$ |
6,892 |
|
|
$ |
(14,785 |
) |
|
$ |
55,784 |
|
Marketable-debt securities |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. treasury securities |
|
|
32,674 |
|
|
|
331 |
|
|
|
— |
|
|
|
33,005 |
|
Corporate bonds |
|
|
13,802 |
|
|
|
147 |
|
|
|
(69 |
) |
|
|
13,880 |
|
Total marketable-debt securities |
|
|
46,476 |
|
|
|
478 |
|
|
|
(69 |
) |
|
|
46,885 |
|
Total marketable securities |
|
$ |
110,153 |
|
|
$ |
7,370 |
|
|
$ |
(14,854 |
) |
|
$ |
102,669 |
|
|
| Derivatives Not Designated as Hedging Instruments |
Immersion’s derivative instruments consisted of call and put options sold at their fair value at the balance sheet date. These derivative instruments are reported as Other current liabilities on our Consolidated Balance Sheets as of April 30, 2026 and 2025 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
April 30, 2026 |
|
|
|
Cost |
|
|
Unrealized Gains (Losses) |
|
|
Fair Value |
|
Derivative instruments |
|
$ |
10,690 |
|
|
$ |
1,185 |
|
|
$ |
11,875 |
|
Total |
|
$ |
10,690 |
|
|
$ |
1,185 |
|
|
$ |
11,875 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
April 30, 2025 |
|
|
|
Cost |
|
|
Unrealized Gains (Losses) |
|
|
Fair Value |
|
Derivative instruments |
|
$ |
6,045 |
|
|
$ |
3,709 |
|
|
$ |
9,754 |
|
Total |
|
$ |
6,045 |
|
|
$ |
3,709 |
|
|
$ |
9,754 |
|
|
| Schedule of realized and unrealized gains and losses from equity securities and derivative instruments and realized gains and losses from marketable debt securities |
The following summarizes the realized and unrealized gains and losses from Immersion’s equity securities and derivative instruments and realized gains and losses from our marketable-debt securities for the following periods (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year Ended April 30,
2026 |
|
|
Fiscal Year Ended April 30,
2025 |
|
Net unrealized gains (losses) recognized on marketable-equity securities |
|
$ |
2,974 |
|
|
$ |
(7,744 |
) |
Net realized gains (losses) recognized on marketable-equity securities |
|
|
(6,618 |
) |
|
|
6,538 |
|
Net unrealized gains (losses) recognized on derivative instruments |
|
|
2,525 |
|
|
|
(6,204 |
) |
Net realized gains (losses) recognized on derivative instruments |
|
|
6,884 |
|
|
|
10,192 |
|
Net realized gains (losses) recognized on marketable-debt securities |
|
|
(107 |
) |
|
|
2,604 |
|
Total net gains (losses) recognized in interest income and other income (expense), net |
|
$ |
5,658 |
|
|
$ |
5,386 |
|
|
| Schedule of financial instruments measured at fair value on recurring basis |
Immersion’s financial instruments measured at fair value, on a recurring basis, at April 30, 2026 and 2025, are classified based on the valuation technique below (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
April 30, 2026 |
|
|
|
Fair Value Measurements Using |
|
|
|
|
|
|
Quoted Prices in Active Markets for Identical Assets (Level 1) |
|
|
Significant Other Observable Inputs (Level 2) |
|
|
Significant Unobservable Inputs (Level 3) |
|
|
Total |
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds (within cash and cash equivalents) |
|
$ |
109,631 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
109,631 |
|
Equity securities |
|
|
42,168 |
|
|
|
— |
|
|
|
— |
|
|
|
42,168 |
|
Total assets at fair value |
|
$ |
151,799 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
151,799 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
Derivative instruments |
|
$ |
2,166 |
|
|
$ |
9,709 |
|
|
$ |
— |
|
|
$ |
11,875 |
|
Total liabilities at fair value |
|
$ |
2,166 |
|
|
$ |
9,709 |
|
|
$ |
— |
|
|
$ |
11,875 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
April 30, 2025 |
|
|
|
Fair Value Measurements Using |
|
|
|
|
|
|
Quoted Prices in Active Markets for Identical Assets (Level 1) |
|
|
Significant Other Observable Inputs (Level 2) |
|
|
Significant Unobservable Inputs (Level 3) |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds (within cash and cash equivalents) |
|
$ |
59,747 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
59,747 |
|
U.S. treasury securities |
|
|
— |
|
|
|
33,005 |
|
|
|
— |
|
|
|
33,005 |
|
Equity securities |
|
|
55,784 |
|
|
|
— |
|
|
|
— |
|
|
|
55,784 |
|
Corporate bonds |
|
|
3,272 |
|
|
|
10,608 |
|
|
|
— |
|
|
|
13,880 |
|
Total assets at fair value |
|
$ |
118,803 |
|
|
$ |
43,613 |
|
|
$ |
— |
|
|
$ |
162,416 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
Derivative instruments |
|
$ |
6,456 |
|
|
$ |
3,298 |
|
|
$ |
— |
|
|
$ |
9,754 |
|
Total liabilities at fair value |
|
$ |
6,456 |
|
|
$ |
3,298 |
|
|
$ |
— |
|
|
$ |
9,754 |
|
|